| Should medicinal chemists do molecular modelling? | |
| | |
MedLine Citation:
|
PMID: 22269135 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
In this article we discuss the pros and cons of medicinal chemists undertaking three-dimensional (3D) computer-aided drug design (CADD) activities for themselves, from the viewpoint of both medicinal chemists and computational chemists. We describe how best this can be implemented, the potential benefits that can be obtained and the pitfalls that are often encountered. |
| | |
Authors:
|
Timothy J Ritchie; Iain M McLay |
Related Documents
:
|
22317355 - Organizational factors related to occupational accidents in construction. 17012765 - Croton lobatus, an african medicinal plant: spectroscopic and chemical elucidation of i... 7648075 - Organizational transition: managing through rough waters. 22279715 - Employee and customer satisfaction in healthcare. 11368115 - John keats and tuberculosis. 20723095 - Anesthetic management of congenital tracheoesophageal fistula. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-1-16 |
Journal Detail:
|
Title: Drug discovery today Volume: - ISSN: 1878-5832 ISO Abbreviation: - Publication Date: 2012 Jan |
Date Detail:
|
Created Date: 2012-1-24 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9604391 Medline TA: Drug Discov Today Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
Copyright © 2012. Published by Elsevier Ltd. |
Affiliation:
|
TJR-Chem, Via Alberto 34C, 21020 Ranco (VA), Italy. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: A series of case studies: practical methodology for identifying antinociceptive multi-target drugs.
Next Document: Can we discover pharmacological promiscuity early in the drug discovery process?